Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation (VECOR)

This study has been terminated.
(Change in strategy regarding the product by the company)
Sponsor:
Information provided by (Responsible Party):
Eurofarma Laboratorios S.A.
ClinicalTrials.gov Identifier:
NCT01356992
First received: May 18, 2011
Last updated: June 17, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2013
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)